COVID-19 IgG Lateral Flow Assay

COVID-19 IgG antibody ho'āʻo wikiwiki i loko o 10 min

Nā mea ʻike	SARS-CoV-2
Kaʻina hana	Lateral Flow Assay
ʻAno laʻana	ʻO ke koko holoʻokoʻa, Serum, Plasma
Nā kikoʻī	40 hōʻike / pahu
Code huahana	CoVGLFA-01

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Hoʻolauna Huahana

ʻO Virusee® COVID-19 IgG Lateral Flow Assay kahi immunoassay kahe lateral i hoʻohana ʻia no ka ʻike qualitative o Novel Coronavirus IgG antibody i loko o ke koko holoʻokoʻa / serum / plasma samples in vitro.Hoʻohana nui ʻia ia i ka maʻi maʻi maʻi kōkua o ka pneumonia coronavirus novel.

ʻO ka novel coronavirus kahi maʻi RNA stranded hoʻokahi.ʻAʻole like me ka coronavirus i ʻike ʻia, ʻoi aku ka maʻalahi o ka heluna kanaka no ka Novel Coronavirus, a ʻoi aku ka hoʻoweliweli ʻana i ka poʻe ʻelemakule a i ʻole ka poʻe me nā maʻi kumu.ʻO IgG antibodies maikaʻi kahi hōʻailona koʻikoʻi o nā maʻi coronavirus hou.ʻO ka ʻike ʻana i nā antibodies kikoʻī coronavirus hou e kōkua i ka maʻi maʻi.

Nā hiʻohiʻona

inoa	COVID-19 IgG Lateral Flow Assay
Kaʻina hana	Lateral Flow Assay
ʻAno laʻana	Koko, plasma, serum
Hōʻike	40 hōʻike / pahu
Ka manawa ʻike	10 min
Nā mea ʻike	COVID-19
Paʻa	Paʻa ka pahu no 1 makahiki ma 2-30 ° C

Pōmaikaʻi

wikiwiki
Loaʻa ka hopena i loko o 10 min
Maʻalahi
ʻIke ʻia ka hopena heluhelu, maʻalahi ke wehewehe
Kaʻina hana maʻalahi, me ka ʻole o ka hana paʻakikī

Mālama i ke kumu kūʻai
Hiki ke lawe ʻia a mālama ʻia ka huahana ma ka lumi wela, e hōʻemi ana i nā kumukūʻai
pilikia haʻahaʻa
Ke hoʻāʻo ʻana i ka laʻana koko, e hōʻemi ana i ka pilikia o ke kaʻina hana laʻana
He kūpono no ka nānā ʻana ma ka pūnaewele, ʻaoʻao moe, outpatient

Ke kumu a me ke kumu

ʻO nā Coronaviruses kahi ʻohana nui o nā maʻi maʻi e hoʻoulu ai i ke anu a me nā maʻi koʻikoʻi.Hoʻokumu ʻia ka COVID-19 e kahi maʻi coronavirus hou i ʻike ʻole ʻia ma mua o ke kanaka.ʻO nā hōʻailona maʻamau o ka maʻi e pili ana i nā hōʻailona hanu, ke kuni, pōkole o ka hanu, a me ka dyspnea.I nā hihia koʻikoʻi, hiki i ka maʻi ke hoʻoulu i ka maʻi pneumonia, ka maʻi hanu acute, ka hōʻino ʻole ʻana, a me ka make.ʻAʻohe lāʻau lapaʻau kūikawā no COVID-19 i kēia manawa.ʻO nā ala nui o ka hoʻouna ʻana i ka COVID-19 ʻo nā kulu hanu a me ka hoʻopili pili.Ua hōʻike ʻia nā noiʻi epidemiological e hiki ke ʻimi ʻia nā hihia e pili kokoke ana i nā poʻe me ka maʻi i hoʻopaʻa ʻia.

ʻO ka ʻike ʻana i ka IgM a me ka IgG kikoʻī microbe i loko o ke koko kaʻapuni (he ho'āʻo 'serologic') ma ke ʻano he ala e hoʻoholo ai i ka loaʻa ʻana o ke kanaka i kēlā pathogen, i kēia manawa (IgM) a i ʻole kahi mamao loa (IgG).

Ua ʻike ʻia nā haʻawina like ʻole he ala wikiwiki, maʻalahi a pololei ka ʻike ʻana o IgM a me IgG no ka ʻike ʻana i nā hihia i manaʻo ʻia ʻo SARS-CoV-2.Hiki ke hoʻomaikaʻi ʻia ka pololei diagnostic o COVID-19 e ka hoʻāʻo ʻana i ka waikawa nucleic i nā mea maʻi me ka mōʻaukala o ka maʻi maʻi a i ʻole nā hōʻailona lapaʻau, a me nā scan CT inā pono, a me ka hoʻāʻo ʻana i ka serum-specific IgM a me IgG antibody hoʻāʻo ma hope o ka puka makani.